Extreme lymphoplasmacytosis and hepatic failure associated with sulfasalazine hypersensitivity reaction and a concurrent EBV infection--case report and review of the literature.
We present an unusual case of a patient with extreme lymphoplasmacytosis and hepatic failure in association with a reaction to sulfasalazine and a concurrent Epstein-Barr virus (EBV) infection. Sulfa drugs can cause a wide range of allergic and hypersensitivity reactions and occasionally can lead to a fulminant illness. In the case under discussion the patient had hepatotoxicity, skin rash, fever, and peripheral blood atypical lymphocytosis. Initial impressions suggested the possibility of a malignant lymphoproliferative disorder. Flow cytometry of peripheral blood and a bone marrow biopsy provided clear evidence for a reactive, polyclonal process as opposed to a malignant disorder. Cessation of the offending drug and administration of steroids led to dramatic improvement. This case illustrates that drug hypersensitivity reactions can be manifested by an extreme lymphocytoid leukemoid reaction.
D000328:Adult; D003937:Diagnosis, Differential; D004342:Drug Hypersensitivity / Q000150:complications / Q000209:etiology*; D020031:Epstein-Barr Virus Infections / Q000097:blood / Q000150:complications*; D006801:Humans; D007958:Leukocyte Count; D017093:Liver Failure / Q000097:blood / Q000139:chemically induced / Q000209:etiology* / Q000821:virology; D008218:Lymphocytosis / Q000097:blood / Q000139:chemically induced / Q000188:drug therapy / Q000209:etiology* / Q000821:virology; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D010950:Plasma Cells / Q000473:pathology*; D012460:Sulfasalazine / Q000009:adverse effects*; D016896:Treatment Outcome
D012460:Sulfasalazine; D008775:Methylprednisolone